Literature DB >> 21587224

Misdiagnosis of clear cell renal cell carcinoma.

Vladimir A Valera1, Maria J Merino.   

Abstract

Clear cell renal cell carcinoma (RCC) represents the most common histological subtype of malignant kidney tumors. Based on symptoms alone, clear cell RCC is indistinguishable from other histological classes of RCC unless the tumor is present in the context of an RCC syndrome. Histopathological examination is, therefore, important to accurately identify clear cell RCC. Clear cell RCCs have characteristic morphological criteria; these tumors can be easily identified upon typical presentation, but diagnosis can be challenging when tumor cell pattern is unusual or when availability of tissue samples is limited. In this Review, the clinical, radiological and pathological characteristics of clear cell RCCs are described, as well as the potential tumors that can be confused with clear cell RCC and need to be considered in the differential diagnoses. Finally, the importance of an accurate diagnosis is highlighted in the context of the increasing use of preoperative tissue sampling and the prevalence of clear cell tumors associated with hereditary syndromes, which could have different therapeutic and prognostic implications for patients and their families.

Entities:  

Mesh:

Year:  2011        PMID: 21587224     DOI: 10.1038/nrurol.2011.64

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  71 in total

Review 1.  Renal-cell carcinoma.

Authors:  Herbert T Cohen; Francis J McGovern
Journal:  N Engl J Med       Date:  2005-12-08       Impact factor: 91.245

2.  Conventional renal cancer in a patient with fumarate hydratase mutation.

Authors:  Heli J Lehtonen; Ignacio Blanco; Jose M Piulats; Riitta Herva; Virpi Launonen; Lauri A Aaltonen
Journal:  Hum Pathol       Date:  2007-01-31       Impact factor: 3.466

3.  Accurate molecular classification of renal tumors using microRNA expression.

Authors:  Eddie Fridman; Zohar Dotan; Iris Barshack; Miriam Ben David; Avital Dov; Sarit Tabak; Orit Zion; Sima Benjamin; Hila Benjamin; Hagit Kuker; Camila Avivi; Kinneret Rosenblatt; Sylvie Polak-Charcon; Jacob Ramon; Nitzan Rosenfeld; Yael Spector
Journal:  J Mol Diagn       Date:  2010-07-01       Impact factor: 5.568

Review 4.  Renal cell carcinoma.

Authors:  R J Motzer; P Russo; D M Nanus; W J Berg
Journal:  Curr Probl Cancer       Date:  1997 Jul-Aug       Impact factor: 3.187

5.  Original and reviewed nuclear grading according to the Fuhrman system: a multivariate analysis of 388 patients with conventional renal cell carcinoma.

Authors:  Vincenzo Ficarra; Guido Martignoni; Nicola Maffei; Matteo Brunelli; Giacomo Novara; Luisa Zanolla; Maurizio Pea; Walter Artibani
Journal:  Cancer       Date:  2005-01-01       Impact factor: 6.860

6.  Small renal cell carcinoma: MRI with pathologic correlation.

Authors:  H Shinmoto; Y Yuasa; A Tanimoto; Y Narimatsu; M Jinzaki; K Hiramatsu; M Mukai
Journal:  J Magn Reson Imaging       Date:  1998 May-Jun       Impact factor: 4.813

7.  Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.

Authors:  Pascal Hajj; Sophie Ferlicot; Walid Massoud; Ayman Awad; Yacine Hammoudi; Bernard Charpentier; Antoine Durrbach; Stéphane Droupy; Gérard Benoît
Journal:  Urology       Date:  2009-07-18       Impact factor: 2.649

8.  Diagnostic problems in the subtyping of renal tumors encountered by five pathologists.

Authors:  Intan Kümmerlin; Fiebo ten Kate; Frank Smedts; Thomas Horn; Ferran Algaba; Isabel Trias; Jean de la Rosette; M Pilar Laguna
Journal:  Pathol Res Pract       Date:  2008-10-17       Impact factor: 3.250

9.  Germline SDHB mutations and familial renal cell carcinoma.

Authors:  Christopher Ricketts; Emma R Woodward; Pip Killick; Mark R Morris; Dewi Astuti; Farida Latif; Eamonn R Maher
Journal:  J Natl Cancer Inst       Date:  2008-08-26       Impact factor: 13.506

10.  Epidemiology of kidney cancer.

Authors:  D Pascual; A Borque
Journal:  Adv Urol       Date:  2008-11-04
View more
  17 in total

1.  Kidney cancer: New approaches for high-risk disease.

Authors:  Peter Sidaway
Journal:  Nat Rev Clin Oncol       Date:  2016-10-25       Impact factor: 66.675

2.  Kidney cancer: Papillary features predict survival in ncRCC.

Authors:  Peter Sidaway
Journal:  Nat Rev Urol       Date:  2016-09-20       Impact factor: 14.432

3.  Kidney cancer: Papillary features predict survival in ncRCC.

Authors:  Peter Sidaway
Journal:  Nat Rev Clin Oncol       Date:  2016-09-27       Impact factor: 66.675

4.  Mechanistically distinct cancer-associated mTOR activation clusters predict sensitivity to rapamycin.

Authors:  Jianing Xu; Can G Pham; Steven K Albanese; Yiyu Dong; Toshinao Oyama; Chung-Han Lee; Vanessa Rodrik-Outmezguine; Zhan Yao; Song Han; David Chen; Daniel L Parton; John D Chodera; Neal Rosen; Emily H Cheng; James J Hsieh
Journal:  J Clin Invest       Date:  2016-08-02       Impact factor: 14.808

5.  RNF20 Suppresses Tumorigenesis by Inhibiting the SREBP1c-PTTG1 Axis in Kidney Cancer.

Authors:  Jae Ho Lee; Yong Geun Jeon; Kyoung-Hwa Lee; Hye Won Lee; Jeu Park; Hagoon Jang; Minyong Kang; Hye Sun Lee; Hee Jin Cho; Do-Hyun Nam; Cheol Kwak; Jae Bum Kim
Journal:  Mol Cell Biol       Date:  2017-10-27       Impact factor: 4.272

6.  Expression parameters of the metabolic pathway genes pyruvate dehydrogenase kinase-1 (PDK-1) and DJ-1/PARK7 in renal cell carcinoma (RCC).

Authors:  Daniel Baumunk; Uta Reichelt; Jannis Hildebrandt; Hans Krause; Jan Ebbing; Hannes Cash; Kurt Miller; Martin Schostak; Steffen Weikert
Journal:  World J Urol       Date:  2012-04-29       Impact factor: 4.226

7.  Mapping of carboxypeptidase m in normal human kidney and renal cell carcinoma: expression in tumor-associated neovasculature and macrophages.

Authors:  Catherine J Denis; Nathalie Van Acker; Stefanie De Schepper; Martine De Bie; Luc Andries; Erik Fransen; Dirk Hendriks; Mark M Kockx; Anne-Marie Lambeir
Journal:  J Histochem Cytochem       Date:  2012-11-19       Impact factor: 2.479

Review 8.  Renal cancer biomarkers: the promise of personalized care.

Authors:  Naveen S Vasudev; Peter J Selby; Rosamonde E Banks
Journal:  BMC Med       Date:  2012-09-27       Impact factor: 8.775

9.  Regulatory Effects of microRNA-92 (miR-92) on VHL Gene Expression and the Hypoxic Activation of miR-210 in Clear Cell Renal Cell Carcinoma.

Authors:  Vladimir A Valera; Beatriz A Walter; W Marston Linehan; Maria J Merino
Journal:  J Cancer       Date:  2011-10-21       Impact factor: 4.207

10.  Cholesterol Auxotrophy as a Targetable Vulnerability in Clear Cell Renal Cell Carcinoma.

Authors:  Nicolas Skuli; M Celeste Simon; Romain Riscal; Caroline J Bull; Clementina Mesaros; Jennifer M Finan; Madeleine Carens; Elaine S Ho; Jimmy P Xu; Jason Godfrey; Paul Brennan; Mattias Johansson; Mark P Purdue; Stephen J Chanock; Daniela Mariosa; Nicholas J Timpson; Emma E Vincent; Brian Keith; Ian A Blair
Journal:  Cancer Discov       Date:  2021-12-01       Impact factor: 38.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.